Concurrent chemoradiotherapy plus nimotuzumab versus chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma with a suboptimal response to induction chemotherapy: a randomized phase 2 trial

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-026-71019-5
Affiliations:
4
Authors:
29
Go to article
Institutions Authors Share
State Key Laboratory of Oncology in South China, SYSUCC, China
24.000000
24.000000
24.000000
 0.83
Sun Yat-sen University Cancer Center (SYSUCC), SYSU, China
5.000000
 0.17
Interested in Clinical Sciences?